These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18314890)

  • 21. Miniaturization of powder dissolution measurement and estimation of particle size.
    Avdeef A; Tsinman K; Tsinman O; Sun N; Voloboy D
    Chem Biodivers; 2009 Nov; 6(11):1796-811. PubMed ID: 19937817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
    Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
    Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. USP dissolution IV: comparison of methods.
    Carstensen JT; Lai TY; Prasad VK
    J Pharm Sci; 1978 Sep; 67(9):1303-7. PubMed ID: 690839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of coning phenomena for irregular particles in paddle dissolution test.
    Higuchi M; Nishida S; Yoshihashi Y; Tarada K; Sugano K
    Eur J Pharm Sci; 2015 Aug; 76():213-6. PubMed ID: 25998150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of an in vitro release method for topical particulate delivery systems.
    Lusina Kregar M; Dürrigl M; Rožman A; Jelčić Ž; Cetina-Čižmek B; Filipović-Grčić J
    Int J Pharm; 2015 May; 485(1-2):202-14. PubMed ID: 25772416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved dissolution rate and bioavailability of fenofibrate pellets prepared by wet-milled-drug layering.
    Wang P; Luo Q; Miao Y; Ying L; He H; Cai C; Tang X
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1344-53. PubMed ID: 22283480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics--dissolution rate implications.
    D'Arcy DM; Corrigan OI; Healy AM
    Eur J Pharm Sci; 2006 Feb; 27(2-3):259-67. PubMed ID: 16314078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential Application of USP Paddle and Basket Dissolution Methods in Discriminating for Portioned Moist Snuff and Snus Smokeless Tobacco Products.
    Rahman Z; Dharani S; Khuroo T; Khan MA
    AAPS PharmSciTech; 2021 Jan; 22(1):51. PubMed ID: 33459904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminative Dissolution Method for Benzoyl Metronidazole Oral Suspension.
    da Silva AS; da Rosa Silva CE; Paula FR; da Silva FE
    AAPS PharmSciTech; 2016 Jun; 17(3):778-86. PubMed ID: 26349689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining in vitro and in silico methods for better prediction of surfactant effects on the absorption of poorly water soluble drugs-a fenofibrate case example.
    Berthelsen R; Sjögren E; Jacobsen J; Kristensen J; Holm R; Abrahamsson B; Müllertz A
    Int J Pharm; 2014 Oct; 473(1-2):356-65. PubMed ID: 24997410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can the USP paddle method be used to represent in-vivo hydrodynamics?
    Scholz A; Kostewicz E; Abrahamsson B; Dressman JB
    J Pharm Pharmacol; 2003 Apr; 55(4):443-51. PubMed ID: 12803765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
    Ige PP; Baria RK; Gattani SG
    Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.
    Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H
    Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity of dissolution rate to location in the paddle dissolution apparatus.
    Healy AM; McCarthy LG; Gallagher KM; Corrigan OI
    J Pharm Pharmacol; 2002 Mar; 54(3):441-4. PubMed ID: 11902812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shear distribution and variability in the USP Apparatus 2 under turbulent conditions.
    Kukura J; Baxter JL; Muzzio FJ
    Int J Pharm; 2004 Jul; 279(1-2):9-17. PubMed ID: 15234789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution.
    Tinke AP; Vanhoutte K; De Maesschalck R; Verheyen S; De Winter H
    J Pharm Biomed Anal; 2005 Oct; 39(5):900-7. PubMed ID: 16023816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. General solution for diffusion-controlled dissolution of spherical particles. 2. Evaluation of experimental data.
    Wang J; Flanagan DR
    J Pharm Sci; 2002 Feb; 91(2):534-42. PubMed ID: 11835211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation and optimization of fenofibrate lipospheres using Taguchi's experimental design.
    Saroja C; Lakshmi PK
    Acta Pharm; 2013 Mar; 63(1):71-83. PubMed ID: 23482314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a standardized dissolution test method for inhaled pharmaceutical formulations.
    Son YJ; McConville JT
    Int J Pharm; 2009 Dec; 382(1-2):15-22. PubMed ID: 19665533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.